KT-939 INCI Name & Expand To Whitening And Freckle-Removing

文章预览

Suzhou, 29 October, 2024-Kintor Pharmaceutical Limited (“Kintor Pharma”, HKEX: 9939), announced that  its in-house developed KT-939 has recently received the review approval of the International Nomenclature Cosmetic Ingredient (the “INCI”) by the International Cosmetic Ingredient Nomenclature Committee with assigned Mono ID of 39815. KT-939 is a tyrosinase inhibitor under development by the Company, effectively inhibiting the melanin production with antioxidant and anti-inflammatory effects. If melanocytes produce an excessive amount of melanin, it may lead to skin pigmentation problems. Tyrosinase is a key rate-limiting enzyme in the synthesis of melanin, and inhibiting its activity can curb the production of melanin from the source. The previous enzymology and cellular melanogenesis research conducted by the Company have demonstrated that KT-939 has the strongest tyrosinase inhibitory activity reported to date. Its inhibitory effect on melanin production is significantly s ………………………………